tt-173
Recombinant proteinexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01595360)
Timeline
Indications
Mechanism of action
- Coagulation factor IIISupplementation
F3 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- tt-173
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02687399 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2016 | Thrombotargets Europe S.L |
| NCT02012569 | Phase 2 | Nov 1, 2013 | Thrombotargets Europe S.L |
| NCT01595360 | Phase 1 | Apr 1, 2012 | Thrombotargets Europe S.L |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Thrombotargets Europe S.L | For profit | 3 | 3 | 3 | 2012 |
1 organizations
Page 1 / 1